JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258500

Human LRRC58 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LRRC58 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and 7 bp deletion in exon1 and Insertion of the selection cassette in exon1.
3 Images
Sanger Sequencing - Human LRRC58 knockout HeLa cell lysate (AB258500)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRRC58 knockout HeLa cell lysate (AB258500)

Allele-2 : 1 bp deletion in exon1

Sanger Sequencing - Human LRRC58 knockout HeLa cell lysate (AB258500)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRRC58 knockout HeLa cell lysate (AB258500)

Allele-3 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human LRRC58 knockout HeLa cell lysate (AB258500)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRRC58 knockout HeLa cell lysate (AB258500)

Allele-1 : 7 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and 7 bp deletion in exon1 and Insertion of the selection cassette in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258500-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LRRC58 knockout HeLa cell lysate", "number":"AB258500-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258500-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
LRRC58
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LRRC58 also known as Leucine-rich repeat-containing protein 58 is a protein with a recognized role in cellular processes. It has a molecular mass of around 60 kDa. Researchers observed its expression in various tissues though it is highly expressed in the brain. The leucine-rich repeats within the protein suggest a role in protein-protein interactions wherein it may interact with other cellular components to facilitate specific mechanical functions.
Biological function summary

LRRC58 contributes to cellular processes through its involvement in signaling pathways. While detailed functions are under study there is evidence suggesting that it could form part of larger protein complexes influencing downstream molecular signaling. This interaction possibly regulates cellular growth and differentiation important for maintaining healthy cellular environments.

Pathways

Scientists have linked LRRC58 to the MAPK/ERK signaling pathway which is important in regulating cell division and differentiation. It may interact with proteins such as MEK1/2 and ERK1/2 in this context. Another possible relationship exists with the PI3K/AKT pathway which indicates a role in cell survival and metabolism regulation. The exact mechanism of LRRC58's involvement in these pathways is an area of active research.

LRRC58 has shown potential connections to neurological conditions particularly neurodegenerative diseases. Altered expression levels of LRRC58 could play a role in the progression of such disorders possibly interacting with proteins implicated in these conditions like Tau or Amyloid precursor protein. Further investigation is needed to clarify the interactions between LRRC58 and these proteins in pathological settings.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com